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956Abstract: Temporomandibular disorder and irritable bowel syndrome are comorbid functional
chronic pain disorders of unknown etiology that are triggered/exacerbated by stress. Here we
present baseline phenotypic characterization of a novel animal model to gain insight into the under-
lying mechanisms that contribute to such comorbid pain conditions. In this model, chronic visceral
hypersensitivity, a defining symptom of irritable bowel syndrome, is dependent on 3 factors: estra-
diol, existing chronic somatic pain, and stress. In ovariectomized rats, estradiol replacement followed
by craniofacial muscle injury and stress induced visceral hypersensitivity that persisted for months.
Omission of any 1 factor resulted in a transient (1 week) visceral hypersensitivity from stress alone
or no hypersensitivity (no inflammation or estradiol). Maintenance of visceral hypersensitivity was
estradiol dependent, resolving when estradiol replacement ceased. Referred cutaneous hypersensi-
tivity was concurrent with visceral hypersensitivity. Increased spinal Fos expression suggests induc-
tion of central sensitization. These data demonstrate the development and maintenance of visceral
hypersensitivity in estradiol-replaced animals following distal somatic injury and stress that mimics
some characteristics reported in patients with temporomandibular disorder and comorbid irritable
bowel syndrome. This new animal model is a powerful experimental tool that can be employed to
gain further mechanistic insight into overlapping pain conditions.
Perspective: The majority of patients with temporomandibular disorder report symptoms consis-
tent with irritable bowel syndrome. Stress and female prevalence are common to both conditions.
In a new experimental paradigm in ovariectomized rats with estradiol replacement, masseter inflam-
mation followed by stress induces visceral hypersensitivity that persists for months, modeling these
comorbid pain conditions.
ª 2015 by the American Pain Society. Published by Elsevier Inc. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ular disorder, estrogen.n general, women are more sensitive to pain thanmen
(see17,22 for review), and a greater number of chronic
pain syndromes are more prevalent in women,
including irritable bowel syndrome (IBS) and
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.doi.org/10.1016/j.jpain.2014.06.008these conditions occur largely in premenopausal
women, and symptoms fluctuate across the menstrual
cycle.25,29,40,56 Many patients with IBS or TMD report
additional pain that is considered unrelated to the
primary complaint, resulting in comorbid or
overlapping pain syndromes. For example, patients
with TMD report symptoms consistent with IBS,
chronic pelvic pain, or fibromyalgia.1,21,67 For several
frequently reported chronic pain syndromes, the rate
of comorbidity exceeds 50%, making this a significant
pain management problem.
Several hypotheses have been put forth to explain
these seemingly unrelated comorbid conditions. Psycho-
logical factors including stress and/or depression can
Traub et al The Journal of Pain 957increase the severity of pain syndromes.20,26,44 Although
acute stress can be antinociceptive, for example, stress-
induced analgesia,8 it often is pronociceptive, especially
for visceral stimuli.4,6,12,38 In contrast, chronic stress is
typically pronociceptive. It exacerbates acute pain and
triggers nociceptive episodes in patients with chronic
pain syndromes.19,23 For example, functional
gastrointestinal disorders including IBS are often
comorbid with affective disorders such as depression,
anxiety, panic, and posttraumatic stress disorder.10,35,44
Because stress modulates many pain syndromes, it is
not surprising that patients susceptible to one chronic
pain condition have a high potential for experiencing
multiple conditions during/after stressful situations.
However, the underlying mechanisms are unknown.
Both hormonal fluctuations and stress modulate
nociceptive sensitivity (see61 for review). As nociceptive
stimuli originating in the deep tissues of rodents
are especially susceptible to both the changing hor-
mone levels during the estrous cycle and hormone
replacement following gonadectomy, animal models
can provide useful insight into pain conditions in
women. Likewise, animal models of stress have been
used to try to gain a mechanistic understanding of
functional pain disorders, especially IBS.39 However,
with the exception of diffuse noxious inhibitory
controls/conditioned pain modulation, animal models
to study the interaction of multiple pain conditions
are lacking.
In the present study,we present a newanimalmodel of
chronic visceral hypersensitivity that is dependent on
17b-estradiol (E2), prior injury, stress, and the temporal
sequencing of these variables. This model mimics the
clinical presentation of TMD patients with IBS symptoms,
providing a platform to evaluate factors that contribute
to these overlapping pain syndromes. Portions of this
manuscript have been presented in abstract form.60Methods
Female Sprague Dawley rats (225–250 g) were pur-
chased fromHarlan (Indianapolis, IN) and double housed
in the University of Maryland School of Dentistry animal
facility with a 12-hour light-dark cycle (lights on at 7 AM).
Food and water were available ad libitum. All protocols
were approved by the University of Maryland School of
Medicine Institutional Animal Care and Use Committee
and adhered to guidelines for experimental pain in ani-
mals published by the International Association for the
Study of Pain.Surgery
Rats were anesthetized with isoflurane and ovariecto-
mized using a dorsolateral approach. Electromyogram
(EMG) electrodes made from Teflon-coated 32-gauge
stainless steel wire (Cooner Wire Company, Chatsworth,
CA) were stitched into the ventrolateral abdominal
wall. The electrode leads were tunneled subcutaneously
and exteriorized at the back of the neck. Rats were
treated pre- and postoperatively with buprenorphine(.03 mg/kg, subcutaneously, twice per day for 2 days).
Upon recovery from anesthesia, rats were individually
housed for the duration of the study.Experimental Protocol
The experimental protocol is shown in Fig 1. The objec-
tive was to test the effects of prior injury (craniofacial
masseter muscle inflammation, a model of TMD), stress
(forced swim [FS]), and E2 on visceral and somatic mecha-
nosensitivity. Ten to 14 days following ovariectomy and
electrode placement, rats were injected subcutaneously
with 50 mg E2 or 100 mL safflower oil (vehicle). The
same injection was repeated at 4-day intervals. The bilat-
eral masseter or biceps brachii muscles were injected
with complete Freund’s adjuvant (CFA, 150 mL, 1:1 in sa-
line) or saline (control for CFA injection). FS stress was
produced by placing the rat in a cylindrical container
(40  50 cm) containing 20-cm-deep water at 26C for
10 minutes on the first day and 20 minutes on the next
2 days. The control for stress from the FS was to leave
the rats undisturbed in their home cage. The day
following the last FS was designated day 1. Baseline
data were collected prior to the CFA injection/FS and
then every 4 to 8 days for 6 weeks post stress. This stress
model was chosen because it could be completed be-
tween E2 injections or within one 4-day estrous cycle.
Rats were tested for their visceromotor response (VMR)
to graded intensities of colorectal distention (CRD), their
mechanosensitivity of the lower back (area of referred
pain from the colorectum) and forepaw (test for whole
body mechanosensitivity) using von Frey filaments, and
their threshold to withdrawal from stimulation of the
masseter muscle region using an IITC Electronic von Frey
anesthesiometer (model no. 2290, tip diameter 4 mm;
IITC Life Science Inc, Woodland Hills, CA). The VMR was
measured 24 hours following an E2 or oil injection. Me-
chanosensitivity of the back and forepaw were tested
48 hours following E2 or oil injection, and threshold to
orofacial stimulationwas tested72hours followingthe in-
jection. Not all rats were tested for somatic mechanosen-
sitivity. There was no difference in the magnitude of the
VMR for rats tested for all stimuli (VMR and von Frey on
consecutive days) and those tested only for visceral sensi-
tivity, so the VMR data were pooled.Visceromotor Response
The VMR is the EMG recorded from the abdominal
muscles in response to graded intensities of CRD. On
the appropriate day as indicated in Fig 1, after the E2
or oil injection, rats were fasted overnight. Water was
available ad libitum. The following day, rats were pre-
pared to record the VMR. Rats were briefly sedated
with isoflurane and a 5- to 6-cm balloon attached to Ty-
gon tubing (Cole-Parmer, Vernon Hills, IL) was inserted
into the descending colon and rectum through the
anus. The secured end of the balloon was at least 1 cm
proximal to the external anal sphincter, and the tubing
was taped to the tail. Rats were loosely restrained in
acrylic glass tubes and given 30 minutes to recover
from sedation. The EMG signals were recorded with a
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Figure 1. Experimental design. E2 or oil is injected every 4 days. Day 1 is the first day after the last FS. Abbreviations: V, visceromotor
response; B, F, M, mechanosensitivity testing of the back, forepaw, masseter muscle.
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ware (Cambridge Electronic Design, Cambridge, United
Kingdom). CRDwas produced by inflating the distention
balloon with air. The pressure was monitored and kept
constant by a pressure controller/timing device. Rats
were given 3 graded intensity distention trials
(each trial consisted of 20, 20, 40, 40, 60, 60, 80, 80 mm
Hg distentions; each distention of 20 seconds duration,
with a 3-minute interstimulus interval). The EMG was
rectified, and the mean EMG for the 20 seconds prior
to distention was subtracted from the response during
distention. The response at each pressure for the last 2
trials was averaged to determine the stimulus response
curve. The area under the curve (AUC: sum of responses
at each pressure) was determined as the response of
the rat for that day.Mechanosensitivity
The day following the VMR measurement, rats were
tested for mechanosensitivity. Rats were placed on an
elevated tray (46  36 cm) with 1-cm sides and left for
30minutes to acclimate. Von Frey filaments were applied
to the back at the level of the base of the tail. Each fila-
ment was tested 5 times at 10-second intervals. Filaments
were tested with increasing force ranging from 1 to
200 g. Next, rats were placed on an elevated grated floor
under inverted boxes. After a 30-minute acclimationperiod, rats were stimulated from underneath on the
forepaws with von Frey filaments using the same proto-
col as on the back. The number of withdrawals to each
filament was plotted.
On the third day after the E2 injection, rats were tested
for their response to craniofacial mechanical stimulation
by probing the masseter muscle through the facial skin
using a rigid von Frey filament coupled with a force
transducer (electronic von Frey). This large tip diameter
is used to preferentially activate neuronal receptors
located in deep tissues.59 The force needed to elicit a
withdrawal of the head was recorded following each
of 5 stimulus presentations spaced at approximately
1-minute intervals.Quantification of c-Fos in the Dorsal
Horn
Separate groups of E2- and oil-treated rats were
treated with CFA and FS. One to 2 weeks after the last
swim session, rats were distended to 60 mm Hg for
2 hours (30 seconds on, 90 seconds off) and then
perfused with 4% paraformaldehyde. The T13-L2 (TL)
and L6-S2 (LS) spinal cord segments were removed,
30-mm sections cut, and every fourth section labeled for
c-Fos using standard immunocytochemical protocols.
Cells immunopositive for c-Fos were quantified using a
nonbiased stereologic method.65 Tissue was examined
Figure 2. The duration of visceral hypersensitivity is estrogen
dependent. (A) The magnitude of the visceromotor response
to graded intensities of CRD for E21CFA1FS rats (square),
E21saline1FS rats (circle), and oil1CFA1FS rats (triangle) at
baseline (open symbols), 6 days post FS (filled symbols) and
34 days post FS (half-filled symbols). (B) The AUC of the VMR
at all time points. Symbols represent same treatment groups
shown in (A). The data are normalized to the baseline response
(base). *P < .05, **P < .01, ***P < .001 versus baseline in that
treatment group. (C) The data in (B) collapsed to the overall
mean AUC. ****P < .0001 versus other groups; #P < .05 versus
Traub et al The Journal of Pain 959with the observer (D.D.) blinded as to the experimental
group. Spinal cord sections were randomly selected, and
stereological analysis of the dorsal horn was conducted
using Stereo Investigator software (MBF Bioscience,Willi-
ston, VT). The upper and lower 1 mm of each section was
defined as the guard zone and was not analyzed because
of inhomogeneity of the tissue.A 125mm 125mmcount-
ing frame was used, which yielded a coefficient of error
(CE) less than .1 and a ratio of CE2 to group variance
squared (CV2) less than .5.57
Data Analysis
VMR
It was very difficult to maintain EMG electrodes in rats
for up to 10weeks. There was attrition in each treatment
group over the course of the experiment. At a minimum,
EMG electrodes had to remain in place at least through
day 10 post FS (3 time points) to be included in any
data analysis. Subsequently, there were fewer rats at
later time points, necessitating analysis using 1-way ana-
lyses of variance (ANOVAs) without repeated measures.
For analysis, the AUC for the stimulus response curve
was calculated. The AUC at each time point starting on
day 2 (see Fig 1) was normalized to each rat’s baseline
response, prompting nonparametric analysis (Kruskal-
Wallis 1-way ANOVA) to assess changes from baseline
across time within each treatment group. Multiple
comparisons versus baseline (Dunn’s test) following a
significant ANOVA are reported in the figures.
Mechanosensitivity
The total number of withdrawals to the range of von
Frey filaments (1–200 g) was calculated and plotted
across time for stimulation of the back and forepaw.
The AUC was calculated and normalized to the baseline
AUC. Threshold to withdrawal was determined for stim-
ulation over themasseter muscle. Changes from baseline
across time within a treatment group were determined
by nonparametric 1-way ANOVA.oil1CFA1FS.Results
Prior Injury and Stress Induce Estrogen-
Dependent Visceral Hypersensitivity
The effect on visceral sensitivity of bilateral masseter
injectionwith CFA or saline followed by FSwas examined
in E2- or oil-treated ovariectomized rats. Stimulus-
response curves for 3 time points (baseline, 6 days,
34 days) show a more vigorous response in E21CFA1FS
rats compared to E21saline1FS rats or oil1CFA1FS rats
(Fig 2A). Collapsing the data to obtain the AUC at each
time point over the 6-week test period, there was signif-
icant visceral hypersensitivity compared to baseline in
the E21CFA1FS rats (Kruskal-Wallis 1-way ANOVA,
P < .001, n = 14; Fig 2B). In contrast, oil1CFA1FS failed
to evoke any visceral hypersensitivity (Kruskal-Wallis
1-way ANOVA, P = .4, n = 7; Fig 2B). In the absence of
masseter inflammation, E21saline1FS, there was a sig-
nificant effect of stress in E2-treated rats over 10 days(E21saline1FS: Kruskal-Wallis 1-way ANOVA, P < .05,
n = 10; Fig 2B). However, the P value edged up toward
.07 over 34 days because the additional time points
were not different from baseline. By 42 days, all rats in
this cohort had lost their electrodes. Collapsing the
data post FS across time to get a mean total response,
the magnitude of the VMR in the E21CFA1FS rats
was significantly greater than the E21saline1FS and
oil1CFA1FS rats (1-way ANOVA, P < .0001; Fig 2C). These
data suggest that injury followed by stress induced
profound and long-lasting de novo visceral hypersensi-
tivity that was estrogen dependent.
Six additional experiments were conducted to
strengthen the conclusion that prior injury plus stress
induced E2-dependent chronic visceral hypersensitivity.
First, ovariectomy alone did not induce visceral hypersen-
sitivity. Ovariectomized rats were left unchallenged in
their home cage except to measure the VMR to CRD at
960 The Journal of Pain Modeling Comorbid Pain Conditions in the Ratthe appropriate time points shown in Fig 1. There was no
change in the magnitude of the VMR compared to the
baseline response over 42 days (Kruskal-Wallis 1-way AN-
OVA, P = .33, n = 8). Second, the requirement of E2 in or-
der for injury plus stress to induce chronic visceral
hypersensitivity was demonstrated 2 ways. The oil1-
CFA1FS group (Fig 2) showed no evidence of visceral hy-
persensitivity. This was further confirmed by replacing
the E2 injectionwith oil.When E2was injected according
to the schedule through day 6, visceral sensitivity
increased similar to that observed in the E21CFA1FS
rats. Substitution of safflower oil for E2 on day 9 abro-
gated the visceral hypersensitivity (Kruskal-Wallis 1-way
repeated measures ANOVA, P < .005, n = 6; Fig 3A). By
day 18, or 12 days after the last E2 injection, the magni-
tude of the VMR had further decreased, essentially
eliminating the recovery of the VMR induced by E2
replacement.
Third, in E2-treated rats, inflammation of the masseter
muscles without FS (E21CFA) had no effect on visceral
sensitivity (VMR measured to day 10: Kruskal-Wallis
1-way ANOVA, P = .54, n = 6; Fig 3B). This suggests that
it is a combination of injury plus stress that results in
the prolonged visceral hypersensitivity. Fourth, the order
of the injury and stressor in the E2-treated rats is signifi-
cant. Stress (FS) following an existing injury (masseter
muscle inflammation) evoked the prolonged visceral hy-
persensitivity in E2-treated rats, but stress preceding the
injury produced effects similar to stress alone. When CFA
was injected the day following the last FS (day 1), there
was a significant increase in visceral sensitivity only on
day 2, returning to baseline by day 6 and continuing at
the baseline level through day 18 (Kruskal-Wallis 1-way
ANOVA, P < .05, n = 7; Fig 3C).
Fifth, the site of the initiating injury is not confined to
the masseter muscles. Injection of CFA into the biceps
brachii followed by FS induced visceral hypersensitivity
(Kruskal-Wallis 1-way ANOVA, P < .001; n = 14; Fig 3D),
of similar magnitude and duration as inflammation of
the masseter muscles. In oil-treated rats, CFA injected
into the biceps brachii plus FS did not result in chronic
visceral hypersensitivity. Sixth, the chronic stress-
induced visceral hypersensitivity was not dependent on
the close interval between muscle inflammation and
FS. FS starting 4 or 8 days following masseter inflamma-
tion still resulted in visceral hypersensitivity in E2-
treated rats (Kruskal-Wallis 1-way repeated measures
ANOVA, P < .05 for both 4-day [n = 6] and 8-day [n = 7]
intervals; AUC: P < .002; Figs 3E and 3F).
The effect of E2 on visceral sensitivity was further
tested by examining Fos expression in the spinal cord.
One to 2 weeks after CFA1FS, when there was a clear
distinction in the VMR between E2- and oil-treated
rats, there was significantly more CRD-induced Fos
expression in both regions of spinal cord that receive
colonic afferent input (TL and LS segments) of the
E2-treated rats compared to the oil-treated rats (t-test
for TL, LS, P < .05, n = 7–8/group; Fig 3G). This suggests
the visceral hypersensitivity is at least partially depen-
dent on increased nociceptive processing at the level of
the spinal cord.Mechanosensitivity
Colonic inflammation increases mechanosensitivity in
the area over the lower back, a region of referred pain
from the colon.62 Mechanosensitivity on the lower back
was testedwith von Freyfilaments to determine if visceral
hypersensitivity was associated with referred pain. In
E21CFA1FS rats there was a clear increase in the number
of withdrawals to increasing forces of von Frey filaments
on day 3 (Fig 4A). The increased mechanosensitivity
returned to baseline on day 19. There was amuch smaller
increase in mechanosensitivity on day 3 in the E21sali-
ne1FS rats (Fig 4B) and the oil1CFA1FS rats (Fig 4C).
Comparing the area under the stimulus-response curve
across time points showed significant mechanosensitivity
through at least 15 days in the E21CFA1FS rats (Kruskal-
Wallis 1-way ANOVA, P < .0001; Fig 4D). There was no
overall increase in mechanosensitivity in the other
cohorts (E21saline1FS, P = .36; oil1CFA1FS, P = .19),
although mechanosensitivity was increased by stress in
these cohorts when comparing the 3-day time point to
baseline (Wilcoxon signed rank test, P < .005 for both).
To determine if the increase in mechanosensitivity was
confined to the dermatomes associated with referred
pain from the colorectum or therewas a general increase
inmechanosensitivity, the forepawswere testedwith von
Frey filaments. There was a tendency toward an increase
in mechanosensitivity of the forepaw in the E21CFA1FS
rats (Fig 5A). When the data were pooled (AUC of
stimulus-response curve), therewas no overall significant
effect (Kruskal-Wallis 1-way ANOVA, P = .0942; Fig 5D),
but the 3-day time point was significantly different
from baseline (Wilcoxon signed rank test, P < .005).
Similarly, therewasnooverall increase in forepawmecha-
nosensitivity in the E21saline1FS rats (Kruskal-Wallis
1-way ANOVA, P = .14; Figs 5B and 5D), but sensitivity at
3 days was significantly greater than baseline (Wilcoxon
signed rank test, P < .005). There was no increase in me-
chanosensitivity in the oil1CFA1FS rats (Kruskal-Wallis
1-way ANOVA, P = .94; Figs 5C and 5D). These data
suggest that stress induces mild, short-lasting mechano-
sensitivity that is E2 dependent but is unrelated to the
longer-duration referred mechanohypersensitivity asso-
ciated with the colorectal hypersensitivity.
CFA injection into the masseter muscle increased me-
chanosensitivity to von Frey stimulation in the orofacial
region. In rats injectedwithCFA, therewas approximately
a 50% decrease in threshold 4 days after FS (7 days after
CFA injection [see timeline in Fig 1]; Fig 6). In E21CFA1FS
rats, the increased mechanosensitivity persisted approxi-
mately 20 days post FS (Kruskal-Wallis 1-way ANOVA,
P < .001). In contrast, in oil1CFA1FS rats, mechanosensi-
tivity returned to baseline levels by 8 days post FS (Krus-
kal-Wallis 1-way ANOVA, P < .001). Rats injected with
saline (E21saline1FS) in the masseter muscles showed
no change in mechanosensitivity at any time point.Discussion
Women are generally more susceptible to functional
pain syndromes, many that can be exacerbated by stress.
Figure 3. Chronic visceral hypersensitivity is dependent on E2 and injury (CFA) preceding stress (FS). (A) E2 administered 1 day prior to
VMR testing in CFA1FS rats resulted in chronic visceral hypersensitivity. Substituting safflower oil for E2 at day 9 reversed the hyper-
sensitivity below baseline. *P < .05 versus 10 days. (B) In the absence of stress, E21CFA failed to induce visceral hypersensitivity.
(C) Stress preceding injury (FS1CFA; closed triangles) induced the same magnitude and duration of visceral sensitivity as stress alone
(E21FS; open circles). **P < .01 versus baseline. (D) In E2 rats, biceps brachii inflammation preceding FS induced chronic visceral hy-
persensitivity. *P < .05, **P < .01, ***P < .001 versus baseline. (E) There was chronic visceral hypersensitivity if the period between the
CFA injection and the beginning of the FS was extended to 4 or 8 days. E2 injections were maintained every 4 days. (F) The mean AUC
across time for different intervals between CFA and FS. **P < .01 versus 8 days; xxP < .01, xxxP < .001 versus baseline. (G) CRD-induced
Fos expression in the lumbosacral (LS) and thoracolumbar (TL) spinal cord in E21CFA1FS and oil1CFA1FS rats. *P < .05 versus oil.
Traub et al The Journal of Pain 961Becausemany functional pain syndromes overlap in their
presentation and their underlying mechanisms are un-
clear, satisfactory pain management is difficult to
achieve.1,63,67 It has been suggested that functionalpain syndromes have altered central nervous system
processing as a contributing factor, suggesting a
potential mechanism for extensive comorbidities (see43
for review). Indeed, patients with IBS or TMD have less
Figure 4. Referred pain is estrogen dependent. (A, B, C) The number of withdrawals to graded intensities of von Frey stimulation to
the lower back in E21CFA1FS rats (A), E21saline1FS rats (B), and oil1CFA1FS rats (C). (D) The total number of withdrawals on each
day normalized to the baseline response. *P < .05, ***P < .001 versus baseline, Dunn’s test following significant ANOVA; #P < .005
versus baseline, Wilcoxon signed rank test.
962 The Journal of Pain Modeling Comorbid Pain Conditions in the Ratcentral pain modulation than healthy controls.28,36 In
animal studies, stress or gonadal hormone
manipulation modulates nociceptive processing,
especially of deep tissue, by acting at multiple levels of
the neuraxis (see30,35,39,61 for review). In the current
study, we phenotype a new clinically relevant animal
model to help extend mechanistic studies on
overlapping pain conditions.Figure 5. There is nomechanohypersensitivity in the forepaw. (A, B
stimulation to the forepaw in E21CFA1FS rats (A), E21saline1F
withdrawals on each day normalized to the baseline response. #P <We report that muscle injury followed by FS stress in-
duces visceral hypersensitivity that persists weeks longer
than visceral hypersensitivity induced by FS alone. This
same subchronic stress paradigm induced somatic
thermal and chemical hypersensitivity that lasted
approximately 8 days and sensitized trigeminal nucleus
caudalis neurons to noxious stimulation of the temporo-
mandibular joint.47,50,51 The unique aspect of our model, C) The number of withdrawals to graded intensities of von Frey
S rats (B), and oil1CFA1FS rats (C). (D) The total number of
.005 versus baseline, Wilcoxon signed rank test.
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the stress-induced visceral hypersensitivity from acute or
transient to chronic pain, persisting at least 6 weeks.
Furthermore, the experiments were conducted in ovari-
ectomized rats to allow examination of hormonal modu-
lation. Estradiol replacement was necessary for the
development and maintenance of the chronic visceral
hypersensitivity, consistent with acute visceral pain
studies, suggesting a pronociceptive effect of fluctuating
levels of E2. Therefore, this model has face validity for
the comorbidity of female TMD patients with chronic
abdominal pain and thus can be useful for further
studies to discern mechanisms underlying overlapping
pain conditions.
Three conditions were necessary to induce the chronic
comorbid visceral hypersensitivity. The first was muscle
injury.Muscle inflammation alone did not induce visceral
hypersensitivity. However, injury to muscle can be an
important primer for chronic pain.14,15 For example,
acute injury of the gastrocnemius muscle combined
with stress evoked muscle hyperalgesia that persisted
for more than a month and became bilateral.46 Injury
to craniofacial muscle may provide an even more power-
ful and persistent trigger for chronic pain because
masticatory muscles possess a much reduced ability to
regenerate and repair following injury when compared
to extracranial muscle.13,49 Because TMD affects 4–12%
of the population and more than half of these patients
complain of myalgia,42,58 craniofacial muscle injury
provides a clinically relevant site of injury for this model.
The second condition was stress. Stress is considered a
trigger for the exacerbationof IBS and the accompanying
abdominal pain aswell as TMD. In rodents, stress induced
visceral hypersensitivity of varyingduration,mostly in an-
imal models with a high-anxiety genetic predisposi-
tion.7,24,55,68 Different stressors have slightly different
effects, but exacerbation of the visceral hypersensitivityby prior injury has never been previously demonstrated.
In the current model when the stress paradigm began
during the period of muscle inflammation–induced
hyperalgesia, the visceral hypersensitivity transitioned
from transient to chronic, extending the duration of
the visceral hypersensitivity.
The third condition was circulating E2. IBS is more
prevalent in women than men, and estrogens partially
contribute to the severity of hypersensitivity. Several
retrospective studies report a correlation between the
menstrual cycle and IBS symptoms, the increase in symp-
toms occurring most often during menses or in the
perimenstrual period when E2 and progesterone levels
drop.29,34,45,66 Furthermore, the incidence of IBS
decreases following menopause and increases with
hormone replacement therapy in postmenopausal
women,48,54 suggesting that either elevated gonadal
hormones or fluctuating levels exacerbate abdominal
pain.
Likewise, currently available animal models of pain
arising from the viscera or the temporomandibular joint
fluctuate across the estrous cycle and are sensitive to
hormonal manipulation.3,9,18,31,33,37,41,47,53 Estrogen is
pronociceptive in many visceral pain models in rodents.
Ovariectomy decreased the magnitude of the VMR to
colonic or bladder distention, which was restored by
bolus E2 replacement.31,32,53 An important observation
from the current study is consistent with fluctuating
plasma E2 concentration as a necessary component
for the chronic hypersensitivity. Plasma E2 levels
peak within a few hours following E2 injection in
ovariectomized rats and decline over several days, so
repetitive injections every 4 days mimic the fluctuation
of a normal estrous cycle.31 In rats with masseter inflam-
mation plus stress, E2 was necessary to develop and
maintain the chronic hypersensitivity. When the E2
injections ceased, the hypersensitivity reversed to the
baseline level in 5 days (1 day after the first oil injection).
By 10 days, the magnitude of the VMR further decreased
as the plasma E2 concentration approached that in ovari-
ectomized rats. Although E2 reverses the decrement in
visceral sensitivity induced by ovariectomy, the sensitivity
is not of comparable magnitude to the stress-induced
visceral hypersensitivity observed in injured rats. The
fact that rats repeatedly injected with E2 and stressed,
but not inflamed, only had a transient hypersensitivity
argues that the repetitive E2 injections maintained
normal visceral sensitivity but did not induce or maintain
chronic visceral hypersensitivity.
In addition, the duration of the CFA1stress–induced
muscle hyperalgesiawas also E2 dependent. Themasseter
hypersensitivity persisted almost 2 weeks longer in the
presence of E2 compared to rats with masseter inflam-
mation plus stress that were treated with safflower oil.Prior Injury Transitions Stress-Induced
Visceral Hypersensitivity From Transient
to Chronic
How the nervous system transitions from acute
to chronic pain is poorly understood. A model of
964 The Journal of Pain Modeling Comorbid Pain Conditions in the Rathyperalgesic priming in primary afferent neurons pro-
poses that injury or inflammatory mediators sensitize
the cell to subsequent proinflammatory mediators
resulting in abnormally prolonged mechanical hyperal-
gesia.14,16,27 Projection of primary afferent–derived
hypersensitivity into the spinal cord would implicate
development of central sensitization.
The priming event in the current model was muscle
injury. Because injury outside the temporomandibular
joint region also contributed to comorbid visceral hyper-
sensitivity, this is likely not a phenomenon exclusively
related to the orofacial region. Although this study was
initially designed to model comorbidity between TMD
and IBS, fibromyalgia is also comorbid with IBS.52,63,67
Although biceps brachii inflammation is not a model
of fibromyalgia, it suggests that a more generalized
mechanism of injury plus stress inducing chronic
visceral pain must be considered.
The severity and persistence of muscle inflammation
induces central sensitization in the trigeminal nucleus
caudalis or spinal dorsal horn immediately downstream
from the muscle nociceptive afferents and in supraspinal
sites involved in nociceptive processing. Several of these
supraspinal nuclei overlap with sites affected by stress
(eg, hypothalamus, amygdala). An overlap between
sites of central sensitization and central effects of psy-
chological/physical stress could alter the response from
one stimulus alone. Because there were indications of
central sensitization in the spinal cord that process colo-
rectal input (increased Fos expression), a change in de-
scending modulation is suggested. CRD alone induced
Fos in the spinal cord, and as expected, Fos expression
in the lumbosacral segments was greater than in thethoracolumbar segments. However, in the visceral hy-
persensitive rats, there was significantly greater spinal
cord Fos expression, consistent with increased process-
ing of noxious visceral stimuli at the level of the spinal
cord.
Central sensitization at the level of the spinal cord is
further supported by the observations on referred pain
and hypersensitivity. Cutaneous mechanohypersensitiv-
itywas observed in the area of referred pain from the col-
orectum. This referred hypersensitivity persisted at least
2 weeks in the E21CFA1FS rats, considerably shorter
than the duration of the visceral hypersensitivity. One
possible explanation is that withdrawal from the cuta-
neous stimulus is largely, if not exclusively, spinally medi-
ated, whereas the VMR is dependent on supraspinal
processing. Differences in plasticity of spinal versus
supraspinal structures could contribute to differences
in hypersensitivity between visceral and cutaneous tis-
sue. In addition, there was a shorter-duration mechano-
hypersensitivity induced by stress that was independent
of E2 or CFA. E21stress also induced a short-durationme-
chanohypersensitivity in the forepaw, but it was of lesser
magnitude than that at the back. These data suggest
that visceral hypersensitivity is associated with referred
pain, supporting reports of referred pain following
colonic inflammation and validating the usefulness of
our model.5,62
In summary, a unique model of overlapping pain con-
ditions is presented. It has face validity with features
described in clinical reports of comorbid pain conditions
observed in the clinic. Future studies will use this model
to investigate the peripheral and central mechanisms
underlying overlapping pain conditions.References
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